Sana Saif Ur Rehman

Medicine & Life Sciences

1. Adenocarcinoma 11%
2. Ambulatory Care 14%
3. Appointments and Schedules 12%
4. Artifacts 14%
5. Breast Neoplasms 19%
6. Cardiotoxicity 9%
7. Chronic Disease 11%
8. Cisplatin 13%
9. Comorbidity 13%
10. Complement C1 24%
11. Confidence Intervals 12%
12. Cost-Benefit Analysis 13%
13. Critical Care 13%
14. Delivery of Health Care 9%
15. Disease Management 15%
16. DNA Repair 13%
17. Drug Therapy 16%
18. Esophageal Neoplasms 15%
19. Eye 9%
20. Fluorouracil 15%
21. gemcitabine 8%
22. Health 7%
23. Health Care Costs 13%
24. Heart 9%
25. Hematologic Neoplasms 15%
26. Immunotherapy 13%
27. Infections 9%
28. Irinotecan 35%
29. irinotecan sucrosofate 8%
30. Leucovorin 18%
31. Lung 15%
32. Lung Neoplasms 31%
33. Magnetic Resonance Imaging 10%
34. Metals 13%
35. Molecular Targeted Therapy 20%
36. Mutation 8%
37. Non-Small Cell Lung Carcinoma 57%
38. Orthodontic Brackets 21%
39. Pain 13%
40. Pancreatic Neoplasms 14%
41. Patient Acceptance of Health Care 17%
42. Patient Care 11%
43. Population 9%
44. Quality Improvement 14%
45. Radiosurgery 100%
46. Registries 13%
47. Sickle Cell Anemia 33%
48. Smoking Cessation 15%
49. Survival 40%
50. Therapeutics 15%